News Focus
News Focus
icon url

Lykiri

11/26/23 11:33 AM

#650718 RE: sentiment_stocks #650716

Another error or at least misleading:

"the ones who survived the longest (11% at 30 months)".


https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noad211/7444576?login=false
It’s 13% survival tail at 60 months in Newly Diagnosed GBM and 11,1% survival tail at 30 months in Recurrent GBM.
icon url

flipper44

11/26/23 2:51 PM

#650757 RE: sentiment_stocks #650716

Yep, I tried to give him some benefit of doubt at NYAS, but nope.

He’s a dweeb.
icon url

biosectinvestor

11/26/23 3:13 PM

#650768 RE: sentiment_stocks #650716

He clearly has a number of but especially that other trial I identified as major conflicts not disclosed and he is like a frenemy. A person who cozies up to you, pretends to be your friend, but is only there to get ammunition to take you down. Can’t trust people like that.

And clearly their analysis is filled with false assumptions and fake “facts” that undermine and create a false impression of the research. It is unbelievable that a Harvard professor would engage in such activities but when you look around, over time, I have found that academia is quite cut throat and this kind of activity by seemingly distinguished researchers is far more common than you would think. It’s disgusting.